Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-alpha on oligodendrocytes and astrocytes
very long chain fatty acids; TNF-alpha; cell death; mitochondria; lysosome; peroxisome; glial cells; oligodendrocytes; glioma cells
Abstract :
[en] X-linked adrenoleukodystrophy (X-ALD) is characterized by ABCD1 deficiency. This disease is associated with elevated concentrations of very long chain fatty acids (C24:0 and C26:0) in the plasma and tissues of patients. Under its severe form, brain demyelination and inflammation are observed. Therefore, we determined the effects of C24:0 and C26:0 on glial cells:oligodendrocytes, which synthesize myelin, and astrocytes, which participate in immune response. So, 158N murine oligodendrocytes, rat C6 glioma cells, rat primary cultures of neuronal–glial cells, and of oligodendrocytes were treated for various periods of time in the absence or presence of C24:0 and C26:0 used at plasmatic concentrations found in X-ALD patients (1–5 μM) and higher (10, 20, 40 μM). To evaluate the importance of extrinsic and intrinsic factors, the part taken by TNF-α and reduced Abcd1 level was studied. Whatever the cells considered, no effects on cell growth and/or viability were detected at 1–5 μM, more or less pronounced effects were identified at 10 μM, and an induction of cell death with increased permeability to propidium iodide and loss of transmembrane mitochondrial potential was observed at 20–40 μM. On 158N, cell death was characterized by (i) an increased superoxide anion production at the mitochondrial level; (ii) the presence of vacuoles of different sizes and shapes; a destabilization of lysosomal membrane and a cytoplasmic redistribution of lysosomes; (iii) a modulation of Abcd3/PMP70 and Acox-1 protein expression, and a decrease in catalase activity at the peroxisomal level. When TNF-α was combined with C24:0 or C26:0 and used on 158N cells, C6 cells, and on 158N cells after siRNA mediated knockdown of Abcd1, no or slight potentiation was revealed. Thus, on the different cell models used, an induction of cell death with marked cellular dysfunctions at the mitochondrial, lysosomal, and peroxisomal levels were found with C24:0 and C26:0 at 20 μM and higher. However, in our experimental conditions, plasmatic concentrations of these fatty acids were unable to induce cell death, and organelle dysfunctions on oligodendrocytes and astrocytes, and additional intrinsic and environmental factors, such as reduced Abcd1 level and/or TNF-α, were ineffective to potentiate their side effects.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Baarine, Mauhamad; Centre de Recherche INSERM 866, Université de Bourgogne > ‘Lipides, Nutrition, Cancer’ > Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique, Dijon, France
Ragot, Kevin; Centre de Recherche INSERM 866, Université de Bourgogne > ‘Lipides, Nutrition, Cancer’ > Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique, Dijon, France
Athias, Anne; INSERM IFR100 ‘Santé – STIC’ > Plateau Technique de Lipidomique, Dijon, France
Nury, Thomas; Centre de Recherche INSERM 866, Université de Bourgogne > ‘Lipides, Nutrition, Cancer’ > Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique, Dijon, France
Kattan, Zilal; Centre de Recherche INSERM 866, Université de Bourgogne > ‘Lipides, Nutrition, Cancer’ > Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique, Dijon, France
Genin, Emmanuelle ; Centre de Recherche INSERM 866, Université de Bourgogne > ‘Lipides, Nutrition, Cancer’ > Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique, Dijon, France
Andreoletti, Pierre; Centre de Recherche INSERM 866, Université de Bourgogne > ‘Lipides, Nutrition, Cancer’ > Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique, Dijon, France
Ménétrier, Franck; INRA, UMR Centre des Sciences du Goût et de l’Alimentation (CSGA) > Développement et Dynamique des Préférences et du Comportement Alimentaire, Dijon, France
Riedinger, Jean-Marc; Centre de Lutte Contre le Cancer GF Leclerc > Laboratoire de Biologie Médicale, Dijon, France
Bardou, Marc; INSERM CIC-P 803/CHU de Dijon, Dijon, France
Lizard, Gérard; Centre de Recherche INSERM 866, Université de Bourgogne > ‘Lipides, Nutrition, Cancer’ > Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique, Dijon, France
Language :
English
Title :
Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-alpha on oligodendrocytes and astrocytes
Aktas O., Schulze-Topphoff U., Zipp F. The role of TRAIL/TRAIL receptors in central nervous system pathology. Front Biosci 2007, 12:2912-2921.
Altmeyer A., Jung A.C., Ignat M., Benzina S., Denis J.M., Gueulette J., et al. Pharmacological enhancement of autophagy induced in a hepatocellular carcinoma cell line by high-LET radiation. Anticancer Res 2010, 30:303-310.
Arnauld S., Fidaleo M., Clémencet M.C., Chevillard G., Athias A., Gresti J., et al. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643. Biochimie 2009, 91:1376-1386.
Baarine M., Ragot K., Genin E.C., El Hajj H., Trompier D., Andreoletti P., et al. Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes. J Neurochem 2009, 111:119-131.
Baes M., Aubourg P. Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist 2009, 15:367-379.
Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001, 81:871-927.
Baumgart E., Vanhorebeek I., Grabenbauer M., Borgers M., Declercq P.E., Fahimi H.D., et al. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 2001, 159:1477-1494.
Benzina S., Altmeyer A., Malek F., Dufour P., Denis J.M., Gueulette J., et al. High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells. Cancer Lett 2008, 264:63-70.
Berger J., Gärtner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 2006, 1763:1721-1732.
Bottelbergs A., Verheijden S., Hulshagen L., Gutmann D.H., Goebbels S., Nave K.A., et al. Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes. Glia 2010, 58:1532-1543.
Boya P., Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008, 27:6434-6451.
Deon M., Garcia M.P., Sitta A., Barschak A.G., Coelho D.M., Schimit G.O., et al. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect. Metab Brain Dis 2008, 23:43-49.
Dubois-Dalcq M., Feigenbaum V., Aubourg P. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci 1999, 22:4-12.
Eichler F., Van Haren K. Immune response in leukodystrophies. Pediatr Neurol 2007, 37:235-244.
Eichler F.S., Ren J.Q., Cossoy M., Rietsch A.M., Nagpal S., Moser A.B., et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?. Ann Neurol 2008, 63:729-742.
Feigenbaum V., Gélot A., Casanova P., Daumas-Duport C., Aubourg P., Dubois-Dalcq M. Apoptosis in the central nervous system of cerebral adrenoleukodystrophy patients. Neurobiol Dis 2000, 7(6 Pt B):600-612.
Ferrer I., Aubourg P., Pujol A. General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol 2010, 20:817-830.
Feutz A.C., Pham-Dinh D., Allinquant B., Miehe M., Ghandour S. An immortalized Jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway. Glia 2001, 34:241-252.
Folch J., Lees M., Sloanes Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
Fouquet F., Zhou J.M., Ralston E., Murray K., Troalen F., Magal E., et al. Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 1997, 3:271-285.
Fourcade S., López-Erauskin J., Galino J., Duval C., Naudi A., Jove M., et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 2008, 17:1762-1773.
Fourcade S., Ruiz M., Guilera C., Hahnen E., Brichta L., Naudi A., et al. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Hum Mol Genet 2010, 19:2005-2014.
Galino J., Ruiz M., Fourcade S., Schlüter A., López-Erauskin J., Guilera C., et al. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 2011, 15:2095-2107.
Gärtner J., Valle D. The 70kDa peroxisomal membrane protein: an ATP-binding cassette transporter protein involved in peroxisome biogenesis. Semin Cell Biol 1993, 4:45-52.
Genin E.C., Geillon F., Gondcaille C., Athias A., Gambert P., Trompier D., et al. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2). J Biol Chem 2011, 286:8075-8084.
Gondcaille C., Depreter M., Fourcade S., Lecca M.R., Leclercq S., Martin P.G., et al. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J Cell Biol 2005, 169:93-104.
Guicciardi M.E., Leist M., Gores G.J. Lysosomes in cell death. Oncogene 2004, 23:2881-2890.
Hein S., Schönfeld P., Kahlert S., Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 2008, 17:1750-1761.
Höftberger R., Kunze M., Weinhofer I., Aboul-Enein F., Voigtländer T., Oezen I., et al. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol Dis 2007, 28:165-174.
Hubbard W.C., Moser A.B., Liu A.C., Jones R.O., Steinberg S.J., Lorey F., et al. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Mol Genet Metab 2009, 97:212-220.
Hudspeth M.P., Raymond G.V. Immunopathogenesis of adrenoleukodystrophy: current understanding. J Neuroimmunol 2007, 182:5-12.
Huin C., Schohn H., Hatier R., Bentejac M., Antunes L., Plénat F., et al. Expression of peroxisome proliferator-activated receptors alpha and gamma in differentiating human colon carcinoma Caco-2 cells. Biol Cell 2002, 94:15-27.
Ito M., Blumberg B.M., Mock D.J., Goodman A.D., Moser A.B., Moser H.W., et al. Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 2001, 60:1004-1019.
Kahn E., Baarine M., Dauphin A., Ragot K., Tissot N., Seguin A., et al. Characterization of lipid membrane organization revealed by LAURDAN color shift during cell death induced by 7-ketocholesterol and very long chain fatty acids on 158N murine oligodendrocytes: investigation by mono- and bi-photon spectral imaging confocal microscopy associated with Factor Analysis of Medical Image Sequences (FAMIS). Cytometry A 2011, 79A:293-305.
Kassmann C., Lappe-Siefke C., Baes M., Brügger B., Mildner A., Werner H.K., et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 2007, 39:969-976.
Kemp S., Pujol A., Waterham H.R., van Geel B.M., Boehm C.D., Raymond G.V., et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat 2001, 18:499-515.
Kemp S., Wanders R.J. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007, 90:268-276.
Kemp S., Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol 2010, 20:831-837.
Khan M., Pahan K., Singh A.V., Singh I. Cytokin-induced accumulation of very long chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem 1998, 71:78-87.
Khan M., Singh J., Gilg A.G., Uto T., Singh I. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J Lipid Res 2010, 51:1685-1695.
Kirkman H.N., Gaetani G.F. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci 2007, 32:44-50.
Kobayashi T., Shinnoh N., Kondo A., Yamada T. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 1997, 232:631-636.
Kristensen A.R., Schandorff S., Høyer-Hansen M., Nielsen M.O., Jäättelä M., Dengjel J., et al. Ordered organelle degradation during starvation-induced autophagy. Mol Cell Proteomics 2008, 7:2419-2428.
Kroemer G., Petit P., Zamzami N., Vayssière J.L., Mignotte B. The biochemistry of programmed cell death. FASEB J 1995, 9:1277-1287.
Kroemer G., Jäättelä M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005, 5:886-897.
Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007, 87:99-163.
Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bessède G., et al. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005, 21:97-114.
Lim M. Treating inflammation in childhood neurodegenerative disorders. Dev Med Child Neurol 2011, 53:298-304.
Lizard G., Fournel S., Genestier L., Dhedin N., Chaput C., Flacher M., et al. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 1995, 21:275-283.
Lizard G., Gueldry S., Deckert V., Gambert P., Lagrost L. Evaluation of the cytotoxic effects of some oxysterols and of cholesterol on endothelial cell growth: methodological aspects. Pathol Biol (Paris) 1997, 45:281-290.
Lorz C., Mehmet H. The role of death receptors in neural injury. Front Biosci 2009, 14:583-595.
McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980, 85:890-902.
Manjithaya R., Nazarko T.Y., Farré J.C., Subramani S. Molecular mechanism and physiological role of pexophagy. FEBS Lett 2010, 584:1367-1373.
Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993, 361:726-730.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
Oaxaca-Castillo D., Andreoletti P., Vluggens A., Yu S., van Veldhoven P.P., Reddy J.K., et al. Biochemical characterization of two functional human liver acyl-CoA oxidase isoforms 1a and 1b encoded by a single gene. Biochem Biophys Res Commun 2007, 360:314-319.
Oezen I., Rossmanith W., Forss-Petter S., Kemp S., Voigtländer T., Moser-Thier K., et al. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency. Hum Mol Genet 2005, 14:1127-1137.
Olsson M., Rundquist I., Brunk U. Flow cytofluorometry of lysosomal acridine orange uptake by living cultured cells. Acta Pathol Microbiol Immunol Scand A 1987, 95:159-165.
Paintlia A.S., Gilg A.G., Khan M., Singh A.K., Barbosa E., Singh I. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 2003, 14:425-439.
Paintlia A.S., Paintlia M.K., Singh A.K., Orak J.K., Singh I. Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. Glia 2010, 58:1669-1685.
Pohl J., Ring A., Ehehalt R., Herrmann T., Stremmel W. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc Nutr Soc 2004, 63:259-262.
Powers J.M., Liu Y., Moser A.B., Moser H.W. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 1992, 51:630-643.
Powers J.M., Pei Z., Heinzer A.K., Deering R., Moser A.B., Moser H.W., et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 2005, 64:1067-1079.
Prunet C., Montange T., Véjux A., Laubriet A., Rohmer J.F., Riedinger J.M., et al. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 2006, 69:359-373.
Robinson K.M., Janes M.S., Beckman J.S. The selective detection of mitochondrial superoxide by live cell imaging. Nat Protoc 2008, 3:941-947.
Schrader M., Fahimi H.D. Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol 2004, 122:383-393.
Shao Y., Gao Z., Marks P.A., Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 2004, 101. 18030-.
Singh I., Kishimoto Y. Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds. J Lipid Res 1983, 24:662-665.
Singh I., Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol 2010, 20:838-844.
Schumann U., Subramani S. Special delivery from mitochondria to peroxisomes. Trends Cell Biol 2008, 18:253-256.
Takemoto Y., Suzuki Y., Horibe R., Shimozawa N., Wanders R.J., Kondo N. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev 2003, 25:481-487.
Valianpour F., Selhorst J.J., van Lint L.E., van Gennip A.H., Wanders R.J., Kemp S. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol Genet Metab 2003, 79:189-196.
Vluggens A., Andreoletti P., Viswakarma N., Jia Y., Matsumoto K., Kulik W., et al. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform. Lab Invest 2010, 90:696-708.
Wanders R.J., Ferdinandusse S., Brites P., Kemp S. Peroxisomes, lipid metabolism and lipotoxicity. Biochim Biophys Acta 2010, 1801:272-280.
Wanders R.J., Waterham H.R. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 2006, 75:295-332.
Wilhelm I., Fazakas C., Krizbai I.A. In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 2011, 71:113-128.
Yamashima T., Oikawa S. The role of lysosomal rupture in neuronal death. Prog Neurobiol 2009, 89:343-358.
Yuan X.M., Li W., Brunk U.T., Dalen H., Chang Y.H., Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 2000, 28:208-218.